Income StatementBalance SheetCash FlowSegments
Astera Labs, Inc. logo

Astera Labs, Inc. Cash Flow Statement

Operating, investing, and financing cash movements

Astera Labs, Inc. generated $383.4M in operating cash flow over the trailing twelve months. After $40.6M in capital expenditures, free cash flow was $342.8M. Free cash flow increased 2.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$383.4MNet Cash From Investing (TTM)-$331.5MNet Cash From Financing (TTM)$9.5MCapital Expenditures (TTM)$40.6MDepreciation And Amortization Cf (TTM)$9.4MNet Change In Cash (TTM)$61.4M
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$39.2B
P/E Ratio146.44
ROE21.11%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other non-cash income (expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Amortization of Investment Discount and Premium$3.5M$2.5M$1.9M$1.8M$1.7M$1.2M
Accretion (amortization) of discounts and premiums on investments$3.5M$2.5M$1.9M$1.8M$1.7M$1.2M
Other non-cash income (expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Change in accounts payable$9.2M$2.2M$2.4M-$5.7M$15.3M-$699.0K
Change in accounts receivable$13.4M$31.0M-$45.5M$18.6M$40.3M$51.8M
Change in accrued liabilities$0.0-$11.7M$10.1M$968.0K$16.4M-$20.8M
Change in inventories$18.0M$6.8M$7.8M-$7.5M$5.8M-$346.0K
Change in other assets$8.0M$14.5M$4.0M$38.3M—-$13.9M
Other working capital changes—$1.0M-$1.8M$503.0K$1.5M$1.3M
Depreciation and amortization$1.0M$1.1M$1.4M$1.5M$2.8M$3.7M
Accretion (Amortization) of Investment Discounts and Premiums$3.5M$2.5M$1.9M$1.8M$1.7M$1.2M
Other Non-Cash Income (Expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other Non-cash Income (Expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other Non-cash Income (Expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Net cash from operating activities$39.7M$10.5M$135.4M$78.2M$95.3M$74.6M
Net income—$31.8M$51.2M$91.1M$45.0M$80.3M
Other non-cash income (expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Accretion (Amortization) of Discounts and Premiums, Investments$3.5M$2.5M$1.9M$1.8M$1.7M$1.2M
Warrants contra revenue$449.0K$374.0K$1.8M$1.9M$1.5M$2.1M
Accrued expenses and other liabilities$0.0-$12.4M$10.8M$968.0K$16.4M-$20.8M
Increase (Decrease) in Prepaid Expense and Other Assets$8.0M$14.5M$4.0M$38.3M—-$13.9M
Non-cash operating lease expense$741.0K$696.0K$826.0K$768.0K$643.0K$1.2M
Operating lease right-of-use asset amortization$741.0K$696.0K$826.0K$768.0K$643.0K$1.2M
Other Noncash Income (Expense)—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other Non-cash Income and Expense—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other Non-Cash Adjustments—$1.0M-$1.8M$503.0K$1.5M$1.3M
Other Non-Cash Income and Expense—$1.0M-$1.8M$503.0K$1.5M$1.3M
Accretion (Amortization) of Investment Discounts and Premiums$3.5M$2.5M$1.9M$1.8M$1.7M$1.2M
Stock-based compensation$48.2M$42.4M$35.5M$40.7M$41.4M$48.9M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$0.0$0.0———$65.0M
Capital expenditures$15.4M$4.5M$2.0M$12.3M$18.7M$7.6M
Payment for (Proceeds from) Other Investing Activity$353.3K$0.0———$2.5M
Net cash from investing activities-$91.4M-$3.9M-$63.7M-$101.0M-$72.8M-$94.0M
Other investing activities$353.3K$0.0———$2.5M
Purchases of investments$205.7M$190.8M$213.9M$259.8M$193.3M$156.6M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$24.3M$6.0M$133.3M$65.9M$76.6M$67.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net cash from financing activities$5.7M$386.0K$4.7M$952.0K$3.7M$82.0K
Proceeds from issuance of common stock$2.6M$386.0K$392.0K$952.0K$95.0K$82.0K

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net increase (decrease) in cash—$7.0M$76.4M-$21.9M$26.2M-$19.3M